Eastwood Bio-Medical Canada Inc. (TSXV:EBM)
1.910
+0.180 (10.40%)
Oct 15, 2026, 10:29 AM EST
TSXV:EBM Revenue
Eastwood Bio-Medical Canada had revenue of 149.79K CAD in the quarter ending July 31, 2026, with 19.40% growth. This brings the company's revenue in the last twelve months to 812.12K, up 36.59% year-over-year. In the fiscal year ending October 31, 2025, Eastwood Bio-Medical Canada had annual revenue of 782.08K with 11.40% growth. That makes Eastwood Bio-Medical Canada the 44,349th largest company in the world by revenue and 946th in Canada.
Revenue (ttm)
812.12K
Revenue Growth
+36.59%
P/S Ratio
146.74
Revenue / Employee
n/a
Employees
n/a
Market Cap
131.57M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2025 | 782.08K | 80.00K | 11.40% |
| Oct 31, 2024 | 702.08K | -165.86K | -19.11% |
| Oct 31, 2023 | 867.94K | -431.83K | -33.22% |
| Oct 31, 2022 | 1.30M | 318.71K | 32.49% |
| Oct 31, 2021 | 981.05K | 262.72K | 36.57% |
| Oct 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.